Autonomic drugs in ophthalmology: some problems and promises. I. Directly and indirectly acting parasympathomimetic drugs.
D000287:Administration, Topical; D000818:Animals; D002217:Carbachol / Q000627:therapeutic use; D002386:Cataract / Q000139:chemically induced; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D003263:Contact Lenses, Hydrophilic; D004456:Echothiophate Iodide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005123:Eye / Q000378:metabolism; D005128:Eye Diseases / Q000188:drug therapy*; D005901:Glaucoma / Q000188:drug therapy; D000882:Haplorhini; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D007531:Isoflurophate / Q000627:therapeutic use; D010277:Parasympathomimetics / Q000627:therapeutic use*; D014677:Pharmaceutical Vehicles; D010862:Pilocarpine / Q000008:administration & dosage / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D011220:Pralidoxime Compounds / Q000627:therapeutic use; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D011812:Quinuclidines / Q000627:therapeutic use; D011817:Rabbits
D002800:Cholinesterase Inhibitors; D010277:Parasympathomimetics; D014677:Pharmaceutical Vehicles; D011220:Pralidoxime Compounds; D000644:Quaternary Ammonium Compounds; D011812:Quinuclidines; D010862:Pilocarpine; D007531:Isoflurophate; D002217:Carbachol; D004456:Echothiophate Iodide